Latest Articles

Publication Date
Immunotherapy Continues to Redefine Treamtent Considerations in Advanced/Recurrent Endometrial Cancer - OncLive

Immunotherapy Continues to Redefine Treamtent Considerations in Advanced/Recurrent Endometrial Cancer OncLive

Published: March 6, 2025, 2:32 p.m.
What are the early signs of womb cancer and how is it treated? - MSN

What are the early signs of womb cancer and how is it treated? MSN

Published: March 6, 2025, 6:17 a.m.
The Prognostic Value of Maximum Standardized Uptake Value (SUVmax) of 18F-FDG PET/CT for Risk Stratification and Outcome Prediction in Endometrial Cancer: A Retrospective Analysis - Cureus

The Prognostic Value of Maximum Standardized Uptake Value (SUVmax) of 18F-FDG PET/CT for Risk Stratification and Outcome Prediction in Endometrial Cancer: A Retrospective Analysis Cureus

Published: March 6, 2025, 1:45 a.m.
Deep-learning radiomics model aids in ovarian cancer diagnosis - AuntMinnie

Deep-learning radiomics model aids in ovarian cancer diagnosis AuntMinnie

Published: March 5, 2025, 10:48 p.m.
Dr Wagar on Lenvatinib Plus Pembrolizumab vs Chemo in First-Line Advanced Endometrial Cancer - OncLive

Dr Wagar on Lenvatinib Plus Pembrolizumab vs Chemo in First-Line Advanced Endometrial Cancer OncLive

Published: March 5, 2025, 8:17 p.m.
When to go for colon cancer screening - Bona Magazine

When to go for colon cancer screening Bona Magazine

Published: March 5, 2025, 5:03 p.m.
ASCO Reading Room | Gita Suneja on Shorter Vaginal Radiation for Endometrial Cancer - Medpage Today

ASCO Reading Room | Gita Suneja on Shorter Vaginal Radiation for Endometrial Cancer Medpage Today

Published: March 5, 2025, 4:47 p.m.
Synthetic Braiding Hair Contains Cancer-Causing Chemicals: Consumer Reports - AboutLawsuits.com

Synthetic Braiding Hair Contains Cancer-Causing Chemicals: Consumer Reports AboutLawsuits.com

Published: March 5, 2025, 4 p.m.
20 years ago I'd be dead - but I've beaten cancer & doing Race for Life - Lancashire Evening Post

20 years ago I'd be dead - but I've beaten cancer & doing Race for Life Lancashire Evening Post

Published: March 5, 2025, 3:08 p.m.
Pembrolizumab plus chemotherapy in advanced or recurrent endometrial cancer: overall survival and exploratory analyses of the NRG GY018 phase 3 randomized trial - Nature.com

Pembrolizumab plus chemotherapy in advanced or recurrent endometrial cancer: overall survival and exploratory analyses of the NRG GY018 phase 3 randomized trial Nature.com

Published: March 5, 2025, 11:04 a.m.
Link copied to clipboard!
Subscribe to Our Newsletter

Stay updated with our latest articles!